Recombinant TNFRSF12A (Enavatuzumab Biosimilar) antibody

Catalog No. ABIN7675826

The Human Monoclonal anti-TNFRSF12A (Enavatuzumab Biosimilar) antibody has been validated for ELISA, FACS, BLI, Func and SPR. It is suitable to detect TNFRSF12A (Enavatuzumab Biosimilar) in samples from Human.

Quick Overview for Recombinant TNFRSF12A (Enavatuzumab Biosimilar) antibody (ABIN7675826)

Target: TNFRSF12A (Enavatuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This TNFRSF12A (Enavatuzumab Biosimilar) antibody is un-conjugated

Application: ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-TNFRSF12A (Enavatuzumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-TNFRSF12A / TWEAKR / CD266 Reference Antibody (enavatuzumab)

Characteristics: Anti-TNFRSF12A / TWEAKR / CD266 Reference Antibody (enavatuzumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for TNFRSF12A (Enavatuzumab Biosimilar)

Target: TNFRSF12A (Enavatuzumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: Q9NP84